Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Ignatiadis M, Zardavas D, Lemort M, Wilke C, et al. Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer. PLoS One 2016;11:e0154009.
PMID: 27454930


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016